Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Expands Licensing Agreement With Genencor

NEW YORK, Jan. 21 (GenomeWeb News) - Freemont, Calif.-based Ciphergen Biosystems today announced the expansion of its existing license agreement with Genencor International.


Under the expanded terms of the agreement, Ciphergen said it now has exclusive, worldwide right to use Genencor's Hydrophobic Charge Induction chromatography technology for the production of its MEP HyperCel-brand chromatographic sorbents as well as MEP membranes, both of which are used in the capture, purification, and production of monoclonal antibodies. Ciphergen has the right to both distribute products based on this technology through its own channels and third parties. The agreement also conditionally allows Ciphergen to sub-contract MEP Hypercel manufacturing rights under the license to third parties.


Financial details were not disclosed.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.